Ant Digital Technologies Hosts Trust Bridge Forum at Hong Kong Fintech Week 2024 and Unveils "Dual Chains and One Bridge" Solution
Ant Digital Technologies hosted the Trust Bridge Forum at Hong Kong Fintech Week, bringing together key industry leaders and experts to discuss the opportunities and challenges presented by real-world asset (RWA) tokenization.
Mr. George Chou, Chief Fintech Officer of the Hong Kong Monetary Authority (HKMA), delivered the opening remarks, highlighting HKMA's commitment to driving fintech innovation, particularly through initiatives like Project Ensemble.“The HKMA recognise that CBDCs have the potential to unlock unrealised economic value by transforming the ways we transact and the systems we transact on,” stated Mr. Chou. “Collaboration between the public and private sectors is crucial to success. We look forward to continuing collaboration with the world and all relevant industry participants.”
Dr. Ying Yan, Chief Scientist at Ant Digital Technologies, provided insights into the evolution of Web3 technology and AntChain’s trusted digital-twin technology which is centered around blockchain with "HOU" architecture to support large-scale, high-activity transactions. While many other core technologies (e.g. distributed key management, ZKP and smart contract security) are developed to addresses the real-world challenges of security and trust. Dr. Yan emphasized the importance of ecosystem development, highlighting their open lab and cloud services to foster collaboration and innovation.
During the event, the "Dual Chains and One Bridge" solution was unveiled. The solution aims to bridge the gap between traditional finance and blockchain technology, empowering real-world assets through digitization and streamlined cross-border transactions.
Cobe Zhang, Head of Web3 Product at Ant Digital Technologies, explained that the "Dual Chains and One Bridge" architecture comprises an "Asset Chain," a "Transaction Chain," and the "AntChain Trusted Cross-Chain Bridge." The Asset Chain can digitize physical assets, transforming them into tradable financial products. Meanwhile, the Transaction Chain focuses on tokenizing funds, particularly those from traditional financial institutions, enabling efficient flow and trading through blockchain technology. This allows for seamless cross-border RWA issuance and trading, specifically targeting Hong Kong's financial market.
Mr. Vincent Lau, Global Head of Digital Money at HSBC, shared a commercial bank's perspective on tokenization. "We are witnessing a shift in tokenization interests from virtual or crypto assets to real-world assets. This trend has the potential to unlock new opportunities for asset tokenization and settlement," said Mr. Lau. He introduced HSBC's tokenized deposit use cases and its active participation in various tokenization projects globally, emphasizing the importance of public-private partnerships and building a robust ecosystem.
The panel discussion, moderated by Zhuoqun BIAN, CFO of Ant Digital Technologies, featured insights from industry experts, including Yan WANG, Executive Director of the Department of Debt Financing at CITIC Securities, Alex ZHANG, CEO of Pharos, and Gavin WANG, Chief Investment Officer of SNZ Capital. The panelists discussed the challenges and possibilities of aligning tokenization with traditional finance, as well as the potential for tokenized assets to drive the next phase of growth in the Web3 ecosystem. The conversation highlighted the potential for RWA tokenization to unlock liquidity for a vast array of assets and transform the financial landscape.
"RWA is the key to unlocking a new world," said Zhuoqun BIAN, "and I hope more people will contribute to this endeavor and co-create the future together."
View source version on businesswire.com: https://www.businesswire.com/news/home/20241105703362/en/
Contacts
Media Inquiries
Zhumei Wang
Zhumei.wzm@antgroup.com
(c) 2024 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Smoke Free Sweden: EU’s Outdated Tobacco Strategy Is Failing and Costing Lives6.11.2024 05:47:00 CET | Press Release
New analysis of data by Smoke Free Sweden from the Europe Union’s leading research body reveals how the EU’s outdated tobacco control strategy is losing the war against smoking. The landmark report by global public health experts reveals: At current rates, the EU will not meet its ‘smoke free’ target for another 76 years. Only the adoption of innovative solutions is significantly reducing the deadly toll of cigarettes in countries such as Sweden, which is on the brink of becoming smoke free. Widespread resistance to safer alternatives in other nations has pushed the EU’s average smoking rate five times higher than Sweden’s. Misguided restrictions on vapes have seen Estonia’s smoking rate soar by almost 40% in just three years. Dr. Delon Human, lead author of the report Missing The Target, says: “It is time for the EU to recognise that restrictive policies on safer nicotine alternatives are costing lives. “The data clearly show that countries prioritising harm reduction are achieving th
IFF Reports Third Quarter 2024 Results5.11.2024 22:37:00 CET | Press Release
IFF (NYSE: IFF) reported financial results for the third quarter ended September 30, 2024. Management Commentary “We are pleased to report a strong performance in the third quarter, with growth across all business segments,” stated IFF CEO Erik Fyrwald. “Market recovery off prior year lows and our global team's passion to address the needs of our customers drove notable volume recovery in every division. This achievement, coupled with our focus on productivity, has resulted in significant bottom-line improvement compared to the same period last year. Taking into account our strong performance in the third quarter and our continued cautiously optimistic outlook for the fourth quarter, we are increasing our full year 2024 financial guidance. We are making solid progress but have a lot of exciting work ahead of us to unleash the full potential of IFF.” Third Quarter 2024 Consolidated Financial Results Reported net sales for the third quarter were $2.93 billion, an increase of 4% versus th
Burjeel Holdings and Response Plus Medical launch $1mn Human Energy Health and Wellbeing Award5.11.2024 19:17:00 CET | Press Release
Burjeel Holdings, a leading super-specialty healthcare provider in the MENA region, and Response Plus Medical Services (RPM), the largest pre-hospital care and emergency medical services provider in the region, have jointly launched the $1 million Human Energy Health and Wellbeing Award at ADIPEC 2024 to boost workplace wellness across the global Energy sector. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20241105689488/en/ Burjeel Holdings and Response Plus Medical launch $1mn Human Energy Health and Wellbeing Award (Photo: AETOSWire) The global energy sector has made significant strides in prioritising the health and wellbeing of its workforce. Building on this, Dr. Shamsheer Vayalil, Founder & Chairman – Burjeel Holdings, and Omran Al Khoori, Chairman – RPM Holding, announced the award during ADIPEC 2024, encouraging CEOs from major global energy organisations to further advance wellbeing across the industry. The award fo
BeiGene Highlights Innovative Hematology Portfolio Across B-cell Malignancies at ASH 20245.11.2024 15:05:00 CET | Press Release
BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160; SSE: 688235), a global oncology company, today announced it will share new data across a range of B-cell malignancies and assets, including best-in-class Bruton’s tyrosine kinase (BTK) inhibitor BRUKINSA® (zanubrutinib), at the 66th ASH Annual Meeting and Exposition in San Diego, December 7-10. BeiGene has 21 abstracts accepted at ASH 2024, with four selected for oral presentation. “In the five years since its initial approval, BRUKINSA has become a standard of care for patients facing many B-cell malignancies, and our data featured at ASH demonstrated how long-term follow-up of treatment with BRUKINSA elicited deep and durable responses, including in patients with chronic lymphocytic leukemia and Waldenström’s macroglobulinemia,” said Mehrdad Mobasher, M.D., M.P.H., Chief Medical Officer, Hematology at BeiGene. “BRUKINSA is just the starting point – pipeline data for our BTK degrader BGB-16673 and BCL2 inhibitor sonrotoclax showcase our contin
DirectSens’ Market-Leading LactoSens ® Biosensor Technology Acquired by Kerry Group P.L.C.5.11.2024 14:00:00 CET | Press Release
DirectSens, a pioneer in next generation biosensor technology, announces the acquisition of its LactoSens® technology by Kerry Group, a global leader in taste and nutrition. The acquisition of LactoSens® reflects DirectSens’ success in developing end-to-end biosensor solutions and represents a move by Kerry Group to complement its offering in lactase enzymes. As an indispensable analytical tool, LactoSens® will work alongside Kerry Group’s ingredient solutions, enabling a more integrated offering for food manufacturers. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20241105399369/en/ LactoSens®, Industry Gold Standard Biosensor Kit. Developed and manufactured by DirectSens in Vienna, AUSTRIA, © DirectSens GmbH 2024 “We’re excited to bring LactoSens® into Kerry Group’s portfolio to add a new element to our offering, as we fully integrate LactoSens® into our broader solutions for the food and beverage industry.” — Ronan Moloney
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom